Veverimer for Treatment of Chronic Metabolic Acidosis in Patients with Chronic Kidney Disease

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Dec 14

PMID 33313284

Citations 1

Authors

Anirudh R Gone

Wei Chen

Affiliations

Soon will be listed here.

Citing Articles

Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis.

Liu W, Li L, Zhang X, Dong H, Lu M Front Pharmacol. 2021; 12:643128.

PMID: 33995050 PMC: 8117340. DOI: 10.3389/fphar.2021.643128.

References

Inker L, Astor B, Fox C, Isakova T, Lash J, Peralta C . KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014; 63(5):713-35. DOI: 10.1053/j.ajkd.2014.01.416. View

Chen W, Abramowitz M . Advances in management of chronic metabolic acidosis in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019; 28(5):409-416. PMC: 6677263. DOI: 10.1097/MNH.0000000000000524. View

Kraut J, Madias N . Metabolic Acidosis of CKD: An Update. Am J Kidney Dis. 2015; 67(2):307-17. DOI: 10.1053/j.ajkd.2015.08.028. View

Mathur R, Dash S, Gupta N, Prakash S, Saxena S, Bhowmik D . Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial. Ren Fail. 2006; 28(1):1-5. DOI: 10.1080/08860220500461187. View

Bushinsky D, Hostetter T, Klaerner G, Stasiv Y, Lockey C, McNulty S . Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD. Clin J Am Soc Nephrol. 2017; 13(1):26-35. PMC: 5753317. DOI: 10.2215/CJN.07300717. View

Weiner D, Seliger S . Cognitive and physical function in chronic kidney disease. Curr Opin Nephrol Hypertens. 2014; 23(3):291-7. PMC: 4052721. DOI: 10.1097/01.mnh.0000444821.87873.7b. View

Bushinsky D . Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?. Am J Kidney Dis. 2018; 73(6):858-865. DOI: 10.1053/j.ajkd.2018.09.004. View

Kovesdy C, Trivedi B, Anderson J . Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis. 2006; 13(2):183-8. DOI: 10.1053/j.ackd.2006.01.005. View

Xie Y, Bowe B, Mokdad A, Xian H, Yan Y, Li T . Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018; 94(3):567-581. DOI: 10.1016/j.kint.2018.04.011. View

10.

Wesson D, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E . Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. Lancet. 2019; 394(10196):396-406. DOI: 10.1016/S0140-6736(19)31388-1. View

11.

Dubey A, Sahoo J, Vairappan B, Haridasan S, Parameswaran S, Priyamvada P . Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial. Nephrol Dial Transplant. 2018; 35(1):121-129. DOI: 10.1093/ndt/gfy214. View

12.

. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

13.

Chen W, Levy D, Abramowitz M . Acid Base Balance and Progression of Kidney Disease. Semin Nephrol. 2019; 39(4):406-417. PMC: 6629436. DOI: 10.1016/j.semnephrol.2019.04.009. View

14.

Abramowitz M, Melamed M, Bauer C, Raff A, Hostetter T . Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2013; 8(5):714-20. PMC: 3641618. DOI: 10.2215/CJN.08340812. View

15.

Chen W, Abramowitz M . Treatment of metabolic acidosis in patients with CKD. Am J Kidney Dis. 2013; 63(2):311-7. PMC: 3946919. DOI: 10.1053/j.ajkd.2013.06.017. View

16.

Wesson D, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E . Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial. Lancet. 2019; 393(10179):1417-1427. DOI: 10.1016/S0140-6736(18)32562-5. View

17.

Bellasi A, Di Micco L, Santoro D, Marzocco S, De Simone E, Cozzolino M . Correction of metabolic acidosis improves insulin resistance in chronic kidney disease. BMC Nephrol. 2016; 17(1):158. PMC: 5075179. DOI: 10.1186/s12882-016-0372-x. View

18.

Nagami G, Hamm L . Regulation of Acid-Base Balance in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2017; 24(5):274-279. DOI: 10.1053/j.ackd.2017.07.004. View

19.

Chen W, Abramowitz M . Epidemiology of Acid-Base Derangements in CKD. Adv Chronic Kidney Dis. 2017; 24(5):280-288. PMC: 5659723. DOI: 10.1053/j.ackd.2017.08.003. View